US HB6757 | 2021-2022 | 117th Congress
Status
Spectrum: Partisan Bill (Republican 4-0)
Status: Introduced on February 18 2022 - 25% progression, died in committee
Action: 2022-02-21 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on February 18 2022 - 25% progression, died in committee
Action: 2022-02-21 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Summary
To amend title XVIII of the Social Security Act to establish under the Medicare prescription drug program a minimum amount of price concessions for insulin to be passed through to beneficiaries at the point-of-sale, and for other purposes.
Title
Insulin Savings for Patients Act
Sponsors
| Rep. Michael Burgess [R-TX] | Rep. Mariannette Miller-Meeks [R-IA] | Rep. David McKinley [R-WV] | Rep. Jeff Van Drew [R-NJ] |
History
| Date | Chamber | Action |
|---|---|---|
| 2022-02-21 | House | Referred to the Subcommittee on Health. |
| 2022-02-18 | House | Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. |
| 2022-02-18 | House | Introduced in House |
Subjects
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/117th-congress/house-bill/6757/all-info |
| Text | https://www.congress.gov/117/bills/hr6757/BILLS-117hr6757ih.pdf |
